NDC 87063-039 – Hydromorphone Hydrochloride

Hydromorphone Hydrochloride 8 mg/1 · Tablet · Oral

Human Prescription Drug DEA schedule CII

Product NDC87063-039

Product details

Brand name
Hydromorphone Hydrochloride
Generic name
Hydromorphone Hydrochloride
Labeler
ASCLEMED USA INC.
Dosage form
Tablet
Route
Oral
Marketing category
NDA AUTHORIZED GENERIC · NDA019892
Marketed since
November 23, 2009
Listing expires
December 31, 2026
Pharmacologic class
Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Hydromorphone Hydrochloride →

Package NDC codes (9)

Package NDCDescriptionSince
87063-039-01100 TABLET in 1 BOTTLE, PLASTIC (87063-039-01)Dec 4, 2025
87063-039-055 TABLET in 1 BOTTLE, PLASTIC (87063-039-05)Dec 4, 2025
87063-039-077 TABLET in 1 BOTTLE, PLASTIC (87063-039-07)Dec 4, 2025
87063-039-1010 TABLET in 1 BOTTLE, PLASTIC (87063-039-10)Dec 4, 2025
87063-039-1414 TABLET in 1 BOTTLE, PLASTIC (87063-039-14)Dec 4, 2025
87063-039-2020 TABLET in 1 BOTTLE, PLASTIC (87063-039-20)Dec 4, 2025
87063-039-3030 TABLET in 1 BOTTLE, PLASTIC (87063-039-30)Dec 4, 2025
87063-039-6060 TABLET in 1 BOTTLE, PLASTIC (87063-039-60)Dec 4, 2025
87063-039-9090 TABLET in 1 BOTTLE, PLASTIC (87063-039-90)Dec 4, 2025

Other Hydromorphone Hydrochloride products